Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Tenzin Gayden^#¹, Fernando E Sepulveda^#², Dong-Anh Khuong-Quang^#^{3

4}, Jonathan Pratt^#¹, Elvis T Valera^{1

5}, Alexandrine Garrigue², Susan Kelso^{6

7}, Frank Sicheri^{6

7}, Leonie G Mikael¹, Nancy Hamel⁸, Andrea Bajic¹, Rola Dali⁹, Shriya Deshmukh¹⁰, Dzana Dervovic⁶, Daniel Schramek^{6

7}, Frédéric Guerin², Mikko Taipale⁷, Hamid Nikbakht^{1

9}, Jacek Majewski^{1

11}, Despina Moshous¹², Janie Charlebois¹³, Sharon Abish¹³, Christine Bole-Feysot¹⁴, Patrick Nitschke¹⁵, Brigitte Bader-Meunier¹², David Mitchell¹³, Catherine Thieblemont^{16

17}, Maxime Battistella^{17

18}, Simon Gravel¹¹, Van-Hung Nguyen¹⁹, Rachel Conyers^{3

4}, Jean-Sebastien Diana¹², Chris McCormack^{20

21}, H Miles Prince^{22

23}, Marianne Besnard²⁴, Stephane Blanche¹², Paul G Ekert^{3

4}, Sylvie Fraitag²⁵, William D Foulkes^{1

8}, Alain Fischer^{12

26

27}, Bénédicte Neven^{12

27}, David Michonneau^{17

28}, Geneviève de Saint Basile^{29

30}, Nada Jabado^{31

32

33}

Affiliations

¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
² Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
³ Children's Cancer Center, The Royal Children's Hospital and Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁴ Department of Pediatrics, University of Melbourne, Parkville, Victoria, Australia.
⁵ Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
⁶ Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
⁷ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
⁸ Cancer Research Program, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
⁹ Canadian Centre for Computational Genomics, Montreal, Quebec, Canada.
¹⁰ Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
¹¹ McGill University and Genome Quebec Innovation Center, Montreal, Quebec, Canada.
¹² Department of Pediatric Immunology and Hematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
¹³ Division of Hematology and Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
¹⁴ Plateforme de Génomique, Institut Imagine, Paris, France.
¹⁵ Plateforme de Bioinformatique, Université Paris Descartes, Université Sorbonne Paris Cité, Paris, France.
¹⁶ Hematology and Oncology Unit, Saint Louis Hospital, Paris, France.
¹⁷ Paris Diderot University, Université Sorbonne Paris Cité, Paris, France.
¹⁸ Cytology and Pathology Laboratory, Saint Louis Hospital, Paris, France.
¹⁹ Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
²⁰ Department of Surgical Oncology, Peter MacCallum Cancer Institute, University of Melbourne, Melbourne, Victoria, Australia.
²¹ Department of Dermatology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
²² Epworth Healthcare, Melbourne, Victoria, Australia.
²³ Department of Medical Oncology, Sir Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
²⁴ Department of Neonatology, Centre Hospitalier de Polynésie Française, Papeete, French Polynesia.
²⁵ Department of Anatomy and Cytology/Pathology, Centre Hospitalier Universitaire Paris, Hôpital Necker-Enfants Malades, Paris, France.
²⁶ Collège de France, Paris, France.
²⁷ INSERM U1163, Institut Imagine and Université Paris Descartes -Sorbonne Paris Cité, Paris, France.
²⁸ Hematology and Transplantation Unit, Saint Louis Hospital, Paris, France.
²⁹ Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France. genevieve.de-saint-basile@inserm.fr.
³⁰ Centre d'Etudes des Déficits Immunitaires, Centre Hospitalier Universitaire Paris, Hôpital Necker-Enfants Malades, Paris, France. genevieve.de-saint-basile@inserm.fr.
³¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.
³² Department of Pediatrics, McGill University, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.
³³ Research Institute, McGill University Health Centre, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.

^# Contributed equally.

PMID: 30429576
DOI: 10.1038/s41588-018-0304-8

Published Erratum

Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Tenzin Gayden et al. Nat Genet. 2019 Jan.

. 2019 Jan;51(1):196.

doi: 10.1038/s41588-018-0304-8.

Authors

Affiliations

¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
² Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
³ Children's Cancer Center, The Royal Children's Hospital and Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁴ Department of Pediatrics, University of Melbourne, Parkville, Victoria, Australia.
⁵ Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
⁶ Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
⁷ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
⁸ Cancer Research Program, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
⁹ Canadian Centre for Computational Genomics, Montreal, Quebec, Canada.
¹⁰ Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
¹¹ McGill University and Genome Quebec Innovation Center, Montreal, Quebec, Canada.
¹² Department of Pediatric Immunology and Hematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
¹³ Division of Hematology and Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
¹⁴ Plateforme de Génomique, Institut Imagine, Paris, France.
¹⁵ Plateforme de Bioinformatique, Université Paris Descartes, Université Sorbonne Paris Cité, Paris, France.
¹⁶ Hematology and Oncology Unit, Saint Louis Hospital, Paris, France.
¹⁷ Paris Diderot University, Université Sorbonne Paris Cité, Paris, France.
¹⁸ Cytology and Pathology Laboratory, Saint Louis Hospital, Paris, France.
¹⁹ Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
²⁰ Department of Surgical Oncology, Peter MacCallum Cancer Institute, University of Melbourne, Melbourne, Victoria, Australia.
²¹ Department of Dermatology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
²² Epworth Healthcare, Melbourne, Victoria, Australia.
²³ Department of Medical Oncology, Sir Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
²⁴ Department of Neonatology, Centre Hospitalier de Polynésie Française, Papeete, French Polynesia.
²⁵ Department of Anatomy and Cytology/Pathology, Centre Hospitalier Universitaire Paris, Hôpital Necker-Enfants Malades, Paris, France.
²⁶ Collège de France, Paris, France.
²⁷ INSERM U1163, Institut Imagine and Université Paris Descartes -Sorbonne Paris Cité, Paris, France.
²⁸ Hematology and Transplantation Unit, Saint Louis Hospital, Paris, France.
²⁹ Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France. genevieve.de-saint-basile@inserm.fr.
³⁰ Centre d'Etudes des Déficits Immunitaires, Centre Hospitalier Universitaire Paris, Hôpital Necker-Enfants Malades, Paris, France. genevieve.de-saint-basile@inserm.fr.
³¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.
³² Department of Pediatrics, McGill University, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.
³³ Research Institute, McGill University Health Centre, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.

^# Contributed equally.

PMID: 30429576
DOI: 10.1038/s41588-018-0304-8

Abstract

In the version of this article originally published, the main-text sentence "In three patients of European ancestry, we identified the germline variant encoding p.Ile97Met in TIM-3, which was homozygous in two (P12 and P13) and heterozygous in one (P15) in the germline but with no TIM-3 plasma membrane expression in the tumor" misstated the identifiers of the two homozygous individuals, which should have been P13 and P14. The error has been corrected in the HTML, PDF and print versions of the paper.

PubMed Disclaimer

Erratum for

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden T, Sepulveda FE, Khuong-Quang DA, Pratt J, Valera ET, Garrigue A, Kelso S, Sicheri F, Mikael LG, Hamel N, Bajic A, Dali R, Deshmukh S, Dervovic D, Schramek D, Guerin F, Taipale M, Nikbakht H, Majewski J, Moshous D, Charlebois J, Abish S, Bole-Feysot C, Nitschke P, Bader-Meunier B, Mitchell D, Thieblemont C, Battistella M, Gravel S, Nguyen VH, Conyers R, Diana JS, McCormack C, Prince HM, Besnard M, Blanche S, Ekert PG, Fraitag S, Foulkes WD, Fischer A, Neven B, Michonneau D, de Saint Basile G, Jabado N. Gayden T, et al. Nat Genet. 2018 Dec;50(12):1650-1657. doi: 10.1038/s41588-018-0251-4. Epub 2018 Oct 29. Nat Genet. 2018. PMID: 30374066

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Affiliations

Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials